A Phase 1, Randomized, Single Dose, Placebo And Active Controlled, 3-Way Crossover Study To Evaluate The Effect Of A Single Oral Dose Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2012
At a glance
- Drugs Lersivirine; Moxifloxacin
- Indications Bacterial infections; HIV infections
- Focus Adverse reactions
- 27 Feb 2012 Results published in Antimicrobial Agents and Chemotherapy.
- 03 Sep 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 03 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History